Solid Biosciences is a biotech company singularly focused on developing treatments and cures for Duchenne Muscular Dystrophy (DMD). The Company combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. Solid's mission is to improve daily life for patients and attack the roots of DMD.